Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 2
This trial is for people with advanced non small cell lung cancer (NSCLC). Advanced NSCLC can mean one of the following:
the cancer is in both lungs
the cancer has spread outside of the lungs into the surrounding area, or elsewhere in the body
there is a collection of fluid around the lung (pleural effusion) and this fluid contains cancer cells
Recruitment start: 31 January 2019
Recruitment end: 14 October 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
Merck Sharp & Dohme Ltd
Last reviewed: 22 January 2020
CRUK internal database number: 15982